Opus Capital Group, LLC Novartis Ag Transaction History

Opus Capital Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 29, 2021	SELL	$81.78 - $95.14 $182,451 - $212,257	-2,231 Closed	0 $0
Q2 2021 Jul 29, 2021	SELL	$85.24 - $94.15 $38,784 - $42,838	-455 Reduced 16.94%	2,231 $204,000
Q1 2021 Apr 28, 2021	BUY	$83.5 - $98.47 $3,006 - $3,544	36 Added 1.36%	2,686 $230,000
Q4 2020 Jan 29, 2021	SELL	$78.07 - $94.43 $5,464 - $6,610	-70 Reduced 2.57%	2,650 $250,000
Q1 2020 Apr 30, 2020	SELL	$70.67 - $99.01 $15,194 - $21,287	-215 Reduced 7.33%	2,720 $224,000
Q4 2019 Jan 31, 2020	SELL	$84.35 - $95.37 $34,161 - $38,624	-405 Reduced 12.13%	2,935 $278,000
Q3 2019 Nov 04, 2019	SELL	$85.54 - $94.26 $191,609 - $211,142	-2,240 Reduced 40.14%	3,340 $290,000
Q2 2019 Aug 08, 2019	BUY	$75.4 - $92.8 $65,598 - $80,736	870 Added 18.47%	5,580 $510,000
Q3 2018 Nov 06, 2018	SELL	$66.94 - $77.43 $80,662 - $93,303	-1,205 Reduced 20.37%	4,710 $406,000
Q3 2017 Nov 07, 2017	BUY	$74.14 - $77.27 $438,538 - $457,052	5,915	5,915 $508,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Opus Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Opus Capital Group, LLC with notifications on news.